Correction to Bayer, Onyx FDA Priority Review Story
August 27 2013 - 10:15AM
Dow Jones News
"Bayer, Onyx Get FDA Priority Review for Sorafenib For Type of
Cancer" published at 6:29 a.m. EDT mispelled Onyx in the
headline.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals Inc. News Articles